Table 5.

Laboratory values prior to treatment and cycle 4 in patients that completed all 4 PRRT cycles.

Laboratory test mean ± SD [min–max]	n	Prior to treatment (baseline)	Postcycle 4	P-value (paired t test)
Cr (mg/dL)	7	0.87 ± 0.32 (0.53–1.39)	0.75 ± 0.32 (0.20–1.20)	.6274
HgB (g/dL)	7	12.4 ± 1.17 (10.10–14.00)	11.45 ± 2.13 (8.90–15.30)	.6209
WBC (×109 cells/L)	7	6.04 ± 1.09 (4.10–7.40)	5.31 ± 1.86 (4.00–9.80)	.3572
Platelet count (cells/mL)	7	269.44 ± 109.10 (93.00–449.00)	167.00 ± 82.68 (66.00–326.00)	.0292
Total cbilirubin (mg/dL)	6	0.60 ± 0.23 (0.20–.90)	0.69 ± 0.41 (0.20–1.40)	.4987
eGFR (mL/min/1.73 m2)	7	68.47 ± 22.29 (39.2–105.0)	61.14 ± 14.00 (49.20–94.00)	.1422

Cr = creatinine, eGFR = estimated glomerular filtration rate, HgB = hemoglobin, max = maximum, min = minimum, PRRT = peptide receptor radionuclide therapy, SD = standard deviation, WBC = white blood cell.